Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs US Global Jets ETF (JETS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs US Global Jets ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while US Global Jets ETF trades at $27.46 (market cap $878.48M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 14.3× US Global Jets ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and US Global Jets ETF for 26 Days on average.
| HALO | JETS | |
|---|---|---|
Market Cap | $12.58B | $878.48M |
Volume | 2,179,278 | 4,465,925 |
Sector | Health | Sector/Thematic |
52-Week High | $115.22 | $33.53 |
52-Week Low | $61.63 | $23.64 |
Typical Hold Time | 1 Days | 26 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JETS ETF trades at $27.29, down 1.37% amid bearish technical signals with 17 sell indicators versus 4 buy signals. The airline-focused ETF faces headwinds from rising fuel costs and geopolitical tensions, while technical analysis shows strong resistance at $28 and support at $27. Recent news highlights underperformance compared to defense-focused aerospace ETFs and pressure from Middle East conflicts driving up airline operating expenses.
The outlook remains challenging with fuel cost volatility and competitive pressure from alternative aerospace investments. While travel demand provides some support, the ETF's concentration on airline operators exposes investors to cyclical industry risks and margin compression from elevated fuel expenses. Near-term performance depends on fuel price stabilization and geopolitical developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →
